Monoclonal antibodies for copper-64 PET dosimetry and radioimmunotherapy

Cancer Biology and Therapy

Volumn 11, Issue 12, 2011, Pages 1001-1007

  Bryan, Jeffrey N ^a   Jia, Fang ^a   Mohsin, Huma ^a   Sivaguru, Geethapriya ^a   Anderson, Carolyn J ^c,d   Miller, William H ^a   Henry, Carolyn J ^a,b   Lewis, Michael R ^a,b,e  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Colon cancer; Copper 64; Monoclonal antibodies; Nude mice; Positron emission tomography; Radioimmunotherapy; Tumor dosimetry

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID CBR96 CU 64; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID CT84.66 CU 64; COPPER 64; MONOCLONAL ANTIBODY; RADIOISOTOPE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DOSIMETRY; FEMALE; INTERNALIZATION; MOUSE; NONHUMAN; NUDE MOUSE; POSITRON EMISSION TOMOGRAPHY; RADIOIMMUNOTHERAPY; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; COLONIC NEOPLASMS; COPPER RADIOISOTOPES; FEMALE; HUMANS; MICE; MICE, NUDE; POSITRON-EMISSION TOMOGRAPHY; RADIOIMMUNOTHERAPY; SURVIVAL ANALYSIS; TISSUE DISTRIBUTION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79958830086     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.11.12.15528     Document Type: Article

References (21)

1. 67Cu. Proc Natl Acad Sci USA 1996; 93:6814-8.
2. 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model. Clin Cancer Res 1999; 5:3608-16.
3. Bass LA, Wang M, Welch MJ, Anderson CJ. In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. Bioconjug Chem 2000; 11:527-32.
4. Wang M, Caruano AL, Lewis MR, Meyer LA, VanderWaal RP, Anderson CJ. Subcellular localization of radiolabeled somatostatin analogues: implications for targeted radiotherapy of cancer. Cancer Res 2003; 63:6864-9. (Pubitemid 37322969)
5. Bryan JN, Jia F, Mohsin H, Sivaguru G, Miller WH, Anderson CJ, et al. Comparative uptakes and biodistributions of internalizing vs. noninternalizing copper-64 radioimmunoconjugates in cell and animal models of colon cancer. Nucl Med Biol 2005; 32:851-8. (Pubitemid 41509196)
6. Henry CJ, Buss MS, Hellstrom I, Hellstrom KE, Brewer WG, Bryan JN, et al. Clinical evaluation of BR96 sFv-PE40 immunotoxin therapy in canine models of spontaneously occurring invasive carcinoma. Clin Cancer Res 2005; 11:751-5. (Pubitemid 40116904)
7. Hellstrom I, Garrigues HJ, Garrigues U, Hellstrom KE. Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens. Cancer Res 1990; 50:2183-90. (Pubitemid 20115097)
8. Neumaier M, Shively L, Chen FS, Gaida FJ, Ilgen C, Paxton RJ, et al. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells. Cancer Res 1990; 50:2128-34. (Pubitemid 20115088)
9. Martin de las MJ, Gomez-Villamandos JC, Perez J, Mozos E, Estrado M, Mendez A. Immunohistochemical evaluation of canine primary liver carcinomas: distribution of alpha-fetoprotein, carcinoembryonic antigen, keratins and vimentin. Res Vet Sci 1995; 59:124-7.
10. Radi ZA, Miller DL, Hines ME. Rete testis mucinous adenocarcinoma in a dog. Vet Pathol 2004; 41:75-8. (Pubitemid 38146851)
11. Cantile C, Campani D, Menicagli M, Arispici M. Pathological and immunohistochemical studies of choroid plexus carcinoma of the dog. J Comp Pathol 2002; 126:183-93.
12. Briesmiester JE. A General Monte Carlo Code N-Particle Transport Code, version 4A. LA-13709-M. Los Alamos NM, Los Alamos National Laboratory Report 2000.
13. Eiblmaier M, Meyer LA, Anderson CJ. The role of p53 in the trafficking of copper-64 to tumor cell nuclei. Cancer Biol Ther 2008; 7:63-9. (Pubitemid 351590454)
14. Violette S, Poulain L, Dussaulx E, Pepin D, Faussat AM, Chambaz J, et al. Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status. Int J Cancer 2002; 98:498-504. (Pubitemid 34208549)
15. 64Cu small animal PET imaging. Bioorg Med Chem 2009; 17:548-52
16. 2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues. Proc Natl Acad Sci USA 2007; 104:12462-7.
17. 64Cu-labeled chelator somatostatin conjugates in an SSTr2-transfected human tumor cell line. J Nucl Med 2007; 48:1390-6.
18. 64Cu using a biomedical cyclotron. Nucl Med Biol 1997; 24:35-43.
19. Lewis MR, Kao JY, Anderson AL, Shively JE, Raubitschek A. An improved method for conjugating monoclonal antibodies with N-hydroxysulfosuccinimidyl DOTA. Bioconjug Chem 2001; 12:320-4. (Pubitemid 32235486)
20. Anderson CJ, Dehdashti F, Cutler PD, Schwarz SW, Laforest R, Bass LA, et al. 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors. J Nucl Med 2001; 42:213-21. (Pubitemid 32150511)
21. Wu AM, Yazaki PJ, Tsai S, Nguyen K, Anderson AL, McCarthy DW, et al. High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proc Natl Acad Sci USA 2000; 97:8495-500. (Pubitemid 30639701)